BRIEF published on 11/13/2025 at 19:45, 10 months 14 days ago Lancement d'une augmentation de capital par MaaT Pharma Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF published on 11/13/2025 at 19:45, 10 months 14 days ago MaaT Pharma launches a capital increase Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
PRESS RELEASE published on 11/13/2025 at 19:40, 10 months 14 days ago Informations privilégiées / Autres communiqués MaaT Pharma lance une augmentation de capital de 9 millions d'euros pour financer son développement. Offre d'actions nouvelles aux investisseurs. Projets de développement clinique et commercialisation Développement Augmentation De Capital Commercialisation Actions Nouvelles MaaT Pharma
PRESS RELEASE published on 11/13/2025 at 19:40, 10 months 14 days ago Inside Information / Other news releases MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026 Private Placement Investment Capital Increase MaaT Pharma Xervyteg
BRIEF published on 11/05/2025 at 07:35, 10 months 22 days ago MaaT Pharma Reveals Promising Preclinical Data for MaaT034 Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
BRIEF published on 11/05/2025 at 07:35, 10 months 22 days ago MaaT Pharma dévoile des données précliniques prometteuses pour MaaT034 Immunothérapie Traitement Du Cancer MaaT Pharma Thérapie Du Microbiome MaaT034
PRESS RELEASE published on 11/05/2025 at 07:30, 10 months 22 days ago Inside Information / Other news releases MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
PRESS RELEASE published on 11/05/2025 at 07:30, 10 months 22 days ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données précliniques actualisées pour MaaT034 au Congrès SITC, démontrant activation immunitaire et activité anti-tumorale MaaT Pharma Données Précliniques MaaT034 Activation Immunitaire Congrès SITC
BRIEF published on 11/04/2025 at 11:43, 10 months 23 days ago MaaT Pharma Receives BUY Rating from First Berlin Equity Research Biotechnology Clinical Trials Investment Cancer Treatment Microbiome Therapy
BRIEF published on 11/04/2025 at 11:43, 10 months 23 days ago MaaT Pharma reçoit une recommandation d'achat de la part de First Berlin Equity Research. Investissement Biotechnologie Essais Cliniques Traitement Du Cancer Thérapie Du Microbiome
Published on 09/26/2026 at 01:00, 1 day 23 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 2 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 6 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 9 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 7 hours 21 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 8 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 8 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 9 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 16 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 6 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 6 hours ago Availability of the 2026 half-year financial report
